Science Explorer Back to mapMap
Institution · Istituto Tumori Bari

Most cited papers from Istituto Tumori Bari

What are the most cited papers from Istituto Tumori Bari?

The most cited paper from Istituto Tumori Bari is "The repertoire of mutational signatures in human cancer" (Ludmil B. Alexandrov et al., 2020), with 3,854 citations. Next come "Pan-cancer analysis of whole genomes" (3,360) and "Landscape of somatic mutations in 560 breast cancer whole-genome sequences" (2,395).

Showing 50 of 60 papers. Every paper with more than 187 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 The repertoire of mutational signatures in human cancer Ludmil B. Alexandrov et al. · Nature Open access1,384 authors 5 Feb 2020 3,854
2 Pan-cancer analysis of whole genomes Lauri A. Aaltonen et al. · Nature Open access1,324 authors 5 Feb 2020 3,360
3 Landscape of somatic mutations in 560 breast cancer whole-genome sequences Serena Nik‐Zainal et al. · Nature Open access 29 Apr 2016 2,395
4 The evolutionary history of 2,658 cancers Moritz Gerstung et al. · Nature Open access1,441 authors 5 Feb 2020 1,149
5 Patterns of somatic structural variation in human cancer genomes Yilong Li et al. · Nature Open access1,411 authors 5 Feb 2020 1,005
6 Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing Isidro Cortés-Ciriano et al. · Nature Genetics Open access1,407 authors 5 Feb 2020 793
7 Analyses of non-coding somatic drivers in 2,658 cancer whole genomes Esther Rheinbay et al. · Nature Open access1,621 authors 5 Feb 2020 674
8 Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial David Cunningham, István Láng, Eugenio Marcuello et al. · The Lancet Oncology 9 Sep 2013 654
9 Consensus guidelines for the use and interpretation of angiogenesis assays Patrycja Nowak‐Sliwinska et al. · Angiogenesis Open access 15 May 2018 607
10 Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study Francesco Passamonti et al. · The Lancet Haematology Open access 13 Aug 2020 555
11 A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma Omid Hamid, Henrik Schmidt, Aviram Nissan et al. · Journal of Translational Medicine Open access 28 Nov 2011 538
12 Broad targeting of angiogenesis for cancer prevention and therapy Zongwei Wang et al. · Seminars in Cancer Biology Open access 16 Jan 2015 462
13 Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung Cancer Giuseppe Frasci, Vito Lorusso, Nicola Panza et al. · Journal of Clinical Oncology Jul 2000 451
14 Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study Maurizio Muscaritoli et al. · Oncotarget Open access 10 Aug 2017 442
15 Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism Valeria Cagno et al. · Nature Materials Open access 18 Dec 2017 437
16 Genomic basis for RNA alterations in cancer PCAWG Transcriptome Core Group et al. · Nature Open access1,461 authors 5 Feb 2020 425
17 Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23 Chiara Degirolamo, Carlo Sabbà, Antonio Moschetta · Nature Reviews Drug Discovery Review 16 Nov 2015 424
18 The landscape of viral associations in human cancers Marc Zapatka et al. · Nature Genetics Open access1,355 authors 5 Feb 2020 412
19 Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis Erika Mariana Palmieri, Alessio Menga, Rosa Martín‐Pérez et al. · Cell Reports Open access Aug 2017 404
20 Microbiota Modification with Probiotics Induces Hepatic Bile Acid Synthesis via Downregulation of the Fxr-Fgf15 Axis in Mice Chiara Degirolamo, Stefania Rainaldi, Fabiola Bovenga et al. · Cell Reports Open access 22 Mar 2014 355
21 Reprogramming of miRNA networks in cancer and leukemia Stefano Volinia et al. · Genome Research Open access May 2010 353
22 The chick embryo chorioallantoic membrane (CAM). A multifaceted experimental model Doménico Ribatti · Mechanisms of Development Open access 10 May 2016 348
23 Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation Rosa Divella, Raffaele De Luca, Ines Abbate et al. · Journal of Cancer Open access 2016 339
24 The concept of immune surveillance against tumors: The first theories Doménico Ribatti · Oncotarget Open access 18 Oct 2016 329
25 Vascular Endothelial Growth Factor (VEGF) as a Target of Bevacizumab in Cancer: From the Biology to the Clinic Girolamo Ranieri, Rosa Patruno, Eustachio Ruggieri et al. · Current Medicinal Chemistry 10 Jun 2006 329
26 Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer Karol Połom, Luigi Marano, Daniele Marrelli et al. · British journal of surgery Review Nov 2017 326
27 Mitochondrial function — gatekeeper of intestinal epithelial cell homeostasis Eva Rath, Antonio Moschetta, Dirk Haller · Nature Reviews Gastroenterology & Hepatology Review 29 May 2018 322
28 Designing a broad-spectrum integrative approach for cancer prevention and treatment Keith I. Block et al. · Seminars in Cancer Biology Open access180 authors 18 Nov 2015 302
29 Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice Alessio Cortellini et al. · Journal for ImmunoTherapy of Cancer Open access Nov 2020 276
30 Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples Marco Russano, Andrea Napolitano, Giulia Ribelli et al. · Journal of Experimental & Clinical Cancer Research Open access 27 May 2020 270
31 Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma Giuseppe Tiziano Lucarelli, Vanessa Galleggiante, Monica Rutigliano et al. · Oncotarget Open access 14 Apr 2015 260
32 Single-molecule detection with a millimetre-sized transistor Eleonora Macchia, Kyriaki Manoli, Brigitte Holzer et al. · Nature Communications Open access 7 Aug 2018 251
33 A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy Matti Aapro, H. S. Rugo, Antônio Rossi et al. · Annals of Oncology Open access 7 Mar 2014 251
34 Autologous hematopoietic stem cell transplantation in multiple sclerosis Giovanni L. Mancardi et al. · Neurology 12 Feb 2015 250
35 Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma Matteo Rosellini, Andrea Marchetti, Veronica Mollica et al. · Nature Reviews Urology ReviewOpen access 21 Nov 2022 249
36 A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns Wei Jiao et al. · Nature Communications Open access1,385 authors 5 Feb 2020 246
37 Integrative pathway enrichment analysis of multivariate omics data Marta Paczkowska et al. · Nature Communications Open access1,460 authors 5 Feb 2020 243
38 Informal caregiving for cancer patients Francesca Romito, Gil Goldzweig, Claudia Cormio et al. · Cancer Open access 20 May 2013 241
39 Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators Elena Piccinin, Gaetano Villani, Antonio Moschetta · Nature Reviews Gastroenterology & Hepatology ReviewOpen access 5 Dec 2018 240
40 Beyond treatment – Psychosocial and behavioural issues in cancer survivorship research and practice Neil K. Aaronson, Vittorio Mattioli, Ollie Minton et al. · European Journal of Cancer Supplements Open access 29 May 2014 238
41 Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial Paolo A. Ascierto et al. · Journal of Clinical Oncology Sep 2022 236
42 Basic principles of biobanking: from biological samples to precision medicine for patients Laura Annaratone, Giuseppe De Palma, Giuseppina Bonizzi et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin Open access 13 Jul 2021 235
43 Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression Jinheng Wang, Kim De Veirman, Sylvia Faict et al. · The Journal of Pathology Open access 9 Mar 2016 235
44 The chick embryo chorioallantoic membrane as a model for tumor biology Doménico Ribatti · Experimental Cell Research 24 Jun 2014 235
45 NHE1 promotes invadopodial ECM proteolysis through acidification of the peri‐invadopodial space Giovanni Busco, Rosa Angela Cardone, Maria Raffaella Greco et al. · The FASEB Journal 14 Jun 2010 229
46 Small-bowel neoplasms in patients undergoing video capsule endoscopy: a multicenter European study Emanuele Rondonotti, Marco Pennazio, Ervin Tóth et al. · Endoscopy Open access 8 May 2008 228
47 Cell transcriptomic atlas of the non-human primate Macaca fascicularis Lei Han et al. · Nature 13 Apr 2022 227
48 Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia Andrea DeCensi et al. · Journal of Clinical Oncology Open access 11 Apr 2019 219
49 Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study Jin-Feng Huang, Jianfei Shen, Xiao Li et al. · Annals of Translational Medicine Open access Apr 2020 217
50 Uncoupling Nuclear Receptor LXR and Cholesterol Metabolism in Cancer Fabiola Bovenga, Carlo Sabbà, Antonio Moschetta · Cell Metabolism Open access Apr 2015 216

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.